Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Arthritis & Rheumatism

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.1780400117PMID 9008608
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular localization of inflammatory cytokines in human glomerulonephritis

  2004cited by this paper
• Intercellular adhesion molecule-1 is necessary but not sufficient to activate CD4+ T cells. Discovery of a novel costimulator on kidney tubule cells.

  1996cited by this paper
• CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.

  1996cited by this paper
• Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.

  1996cited by this paper
• CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression.

  1995cited by this paper
• Inhibition of the CD40-CD40ligand pathway prevents murine membranous glomerulonephritis.

  1995cited by this paper
• Lupus: key pathogenic mechanisms and contributing factors.

  1995cited by this paper
• Expression of functional CD40 by vascular endothelial cells

  1995cited by this paper
• Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells.

  1995cited by this paper
• Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals

  1995cited by this paper
• Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients.

  1995cited by this paper
• The CD40 ligand expressed by human B cells costimulates B cell responses.

  1995cited by this paper
• CD40 ligand is functionally expressed on human eosinophils

  1995cited by this paper
• Ligation of CD40 on fibroblasts induces CD54 (ICAM‐1) and CD106 (VCAM‐1) up‐regulation and IL‐6 production and proliferation

  1995cited by this paper
• Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.

  1995cited by this paper
• Activation of human dendritic cells through CD40 cross-linking

  1994cited by this paper
• Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin).

  1994cited by this paper
• T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/BB-1) and enhance their costimulatory activity.

  1994cited by this paper
• The CD40 antigen and its ligand.

  1994cited by this paper
• IL-6, IL-8 and TNF production by cytokine and lipopolysaccharide-stimulated human renal cortical epithelial cells in vitro.

  1994cited by this paper
• CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/CD40-L. Potential role in regulating helper effector function.

  1994cited by this paper
• The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation.

  1994cited by this paper
• Isolation of cDNAs encoding T-BAM, a surface glycoprotein on CD4+ T cells mediating contact-dependent helper function for B cells: identity with the CD40-ligand.

  1994cited by this paper
• B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40

  1994cited by this paper
• Induction of B cell costimulatory function by recombinant murine CD40 ligand

  1994cited by this paper
• Mice deficient for the CD40 ligand.

  1994cited by this paper
• The understanding of contact-dependent T-cell helper function in molecular, cellular and physiological detail.

  1994cited by this paper
• Leukocyte adhesion molecules and kidney diseases.

  1994cited by this paper
• Induction of human IgE synthesis in B cells by mast cells and basophils

  1993cited by this paper
• Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal

  1993cited by this paper
• CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40

  1993cited by this paper
• Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40.

  1993cited by this paper
• Recombinant CD40 ligand stimulation of murine B cell growth and differentiation: cooperative effects of cytokines

  1993cited by this paper
• Molecular and biological characterization of a murine ligand for CD40.

  1992cited by this paper
• In vitro and in vivo interleukin-8 production in human renal cortical epithelia.

  1992cited by this paper
• A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells.

  1992cited by this paper
• Intercellular adhesion molecules and vascular cell adhesion molecule-1 and the kidney.

  1992cited by this paper
• Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help.

  1992cited by this paper
• The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co‐stimulatory activity.

  1992cited by this paper
• Tubulointerstitial changes as a major determinant in the progression of renal damage.

  1992cited by this paper
• Activated human T cells express a ligand for the human B cell‐associated antigen CD40 which participates in T cell‐dependent activation of B lymphocytes

  1992cited by this paper
• Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help)

  1992cited by this paper
• CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation.

  1992cited by this paper
• CD40 is functionally expressed on human thymic epithelial cells.

  1992cited by this paper
• Immunodeficiency with hyper-IgM (HIM).

  1992cited by this paper
• Molecular and biological characterization of a murine ligand for CD40

  1992cited by this paper
• Antigen presentation by renal tubular epithelial cells.

  1991cited by this paper
• Expression of Activation Antigens on T Cells in Rheumatoid Arthritis Patients

  1990cited by this paper
• Lupus nephritis: correlation of interstitial cells with glomerular function.

  1990cited by this paper
• Identification of a human epithelial cell surface protein sharing an epitope with the C3d/epstein‐barr virus receptor molecule of B lymphocytes

  1989cited by this paper
• A B‐lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas.

  1989cited by this paper
• Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis.

  1986cited by this paper
• Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis.

  1986cited by this paper
• HLA-Dr+ T cells of the Leu 3 (helper) type infiltrate the kidneys of patients with systemic lupus erythematosus.

  1985cited by this paper
• Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome.

  1984cited by this paper
• Stages of renal ontogenesis identified by monoclonal antibodies reactive with lymphohemopoietic differentiation antigens

  1983cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper
• RENAL INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): A Study of 56 Patients Emphasizing Histologic Classification

  1978cited by this paper

• Revisiting the CD40-CD40L axis: from mechanistic insight to therapeutic renewal in autoimmune disease.

  2026cites this paper
• Efficacy, pharmacokinetics and safety of iscalimab (CFZ533) in patients with proliferative lupus nephritis: a randomised, double-blind, placebo-controlled, phase II study

  2025influential citation
• Circulating anti-nephrin antibody as permeability factor for inducing primary focal segmental glomerular sclerosis and minimal change disease

  2025cites this paper
• Advanced Glycation End Products Upregulate CD40 in Human Retinal Endothelial and Müller Cells: Relevance to Diabetic Retinopathy

  2024cites this paper
• Implications of CD154 and Its Receptors in the Pathogenesis and Treatment of Systemic Lupus Erythematosus

  2024cites this paper
• Lupus Nephritis: Immune Cells and the Kidney Microenvironment

  2024cites this paper
• Safety and tolerability of tegoprubart in patients with amyotrophic lateral sclerosis: A Phase 2A clinical trial

  2024cites this paper
• Drugs in Development to Treat IgA Nephropathy

  2024cites this paper
• Outcome of Patients With Lupus Nephritis Treated With an Anti‐CD40 Monoclonal Antibody According to Kidney Biopsy Features

  2024cites this paper
• Causal relationship between the immune phenotype of monocytes and myasthenia gravis: A Mendelian randomization study

  2024cites this paper
• Role of the CD40-CD40 Ligand Pathway in Cardiovascular Events, Neurological Alterations, and Other Clinical Complications of Chronic Hemodialysis Patients: Protective Role of Adsorptive Membranes

  2023cites this paper
• Serum sCD40L and IL-31 in Association with Early Phase of IgA Nephropathy

  2023cites this paper
• CD40 Upregulation in the Retina of Patients With Diabetic Retinopathy: Association With TRAF2/TRAF6 Upregulation and Inflammatory Molecule Expression

  2023cites this paper
• Clinical research progress of novel biologics for the treatment of lupus nephritis

  2023cites this paper
• Human Oral Epithelial Cells Suppress T Cell Function via Prostaglandin E2 Secretion

  2022cites this paper
• The Inhibition of CD40/CD154 Costimulatory Signaling in the Prevention of Renal Transplant Rejection in Nonhuman Primates: A Systematic Review and Meta Analysis

  2022cites this paper
• Mesangial cell: A hub in lupus nephritis

  2022cites this paper
• IgA nephropathy: an overview of drug treatments in clinical trials

  2022cites this paper
• Kidney organoid systems for studies of immune-mediated kidney diseases: challenges and opportunities

  2021cites this paper
• Escape from X chromosome inactivation and female bias of autoimmune diseases

  2020cites this paper
• CD40/CD40L Signaling as a Promising Therapeutic Target for the Treatment of Renal Disease

  2020cites this paper
• First‐in‐human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti‐CD40 monoclonal antibody

  2020cites this paper
• Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis.

  2020cites this paper
• Diabetes enhances translation of Cd40 mRNA in murine retinal Müller glia via a 4E-BP1/2–dependent mechanism

  2020cites this paper
• Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study

  2019cites this paper
• The CD40-ATP-P2X7 Receptor Pathway: Cell to Cell Cross-Talk to Promote Inflammation and Programmed Cell Death of Endothelial Cells

  2019cites this paper
• Current Paradigms of Tolerogenic Dendritic Cells and Clinical Implications for Systemic Lupus Erythematosus

  2019cites this paper
• SLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid Lupus

  2019cites this paper
• Treatment with a CD40 Antagonist Antibody Reverses Severe Proteinuria and Loss of Saliva Production and Restores Glomerular Morphology in Murine Systemic Lupus Erythematosus

  2019cites this paper
• Pim‐1 as a Therapeutic Target in Lupus Nephritis

  2019cites this paper
• The non-haemostatic role of platelets in systemic lupus erythematosus

  2018cites this paper
• Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 655064, an Antagonistic Anti‐CD40 Antibody, in Healthy Subjects: A Potential Novel Treatment for Autoimmune Diseases

  2018cites this paper
• Serum protein pattern associated with organ damage and lupus nephritis in systemic lupus erythematosus revealed by PEA immunoassay

  2017cites this paper
• Intrapancreatic injection of human bone marrow-derived mesenchymal stem/stromal cells alleviates hyperglycemia and modulates the macrophage state in streptozotocin-induced type 1 diabetic mice

  2017cites this paper
• SIRT1 regulates lipopolysaccharide‐induced CD40 expression in renal medullary collecting duct cells by suppressing the TLR4‐NF‐&kgr;B signaling pathway

  2017cites this paper
• Hydroxychloroquine inhibits CD154 expression in CD4+ T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling

  2017cites this paper
• tubule cells TRAF6 recruitment, and MAPK activation in proximal CD40 ligation stimulates MCP-1 and IL-8 production,

  2016cites this paper
• CD154 Induces Matrix Metalloproteinase‐9 Secretion in Human Podocytes

  2016cites this paper
• The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkers

  2015cites this paper
• CD40 Generation 2.5 Antisense Oligonucleotide Treatment Attenuates Doxorubicin-induced Nephropathy and Kidney Inflammation

  2015cites this paper
• Blockade of CD40–TRAF2,3 or CD40–TRAF6 is sufficient to inhibit pro‐inflammatory responses in non‐haematopoietic cells

  2015cites this paper
• Endoplasmic reticulum stress preconditioning antagonizes low-density lipoprotein-induced inflammation in human mesangial cells through upregulation of XBP1 and suppression of the IRE1α/IKK/NF-κB pathway.

  2015cites this paper
• Costimulatory blockade: A novel approach to the treatment of glomerular disease?

  2015cites this paper
• Proinflammatory responses induced by CD40 in retinal endothelial and Müller cells are inhibited by blocking CD40-Traf2,3 or CD40-Traf6 signaling.

  2014cites this paper
• CD 154 : An ImmunoinflammatoryMediator in Systemic Lupus Erythematosus and Rheumatoid Arthritis

  2014cites this paper
• CD40 expression in renal cell carcinoma is associated with tumor apoptosis, CD8(+) T cell frequency and patient survival.

  2014cites this paper
• Association of genetic polymorphisms in CD40 with susceptibility to SLE in the Korean population.

  2013cites this paper
• Aberrant CD40-Induced NF-κB Activation in Human Lupus B Lymphocytes

  2012cites this paper
• Pathogenesis of Lupus Nephritis

  2011cites this paper
• Система CD40 - лиганд CD40 в развитии сахарного диабета и его осложнений

  2011cites this paper
• Lupus nephritis: current update

  2011cites this paper
• In vivo therapeutic efficacy of intra-renal CD40 silencing in a model of humoral acute rejection

  2011cites this paper
• CD154: An Immunoinflammatory Mediator in Systemic Lupus Erythematosus and Rheumatoid Arthritis

  2011cites this paper
• The role of CD40 receptor-ligand system in the development of diabetes mellitus and its complications

  2011cites this paper
• Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis.

  2010cites this paper
• Lupus and T Cells

  2009cites this paper
• New therapies in development for autoimmune diseases: their rationale for combination treatment

  2009cites this paper
• [Biotherapy of auto-immune diseases : past, present and future perspectives].

  2009cites this paper
• Epithelial cells as immune effector cells: the role of CD40.

  2009cites this paper
• Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: implications for the amplification of the inflammatory response

  2009cites this paper
• Lupus and T cells.

  2009cites this paper
• Antibody-based therapies in systemic lupus erythematosus.

  2009cites this paper
• Lupus systémique : les traitements du futur

  2008cites this paper
• Effects of different LDL particles on inflammatory molecules in human mesangial cells

  2008cites this paper
• [Systemic lupus erythematosus: future therapeutic avenues].

  2008cites this paper
• TGF-Beta Treatment Modulates PD-L1 and CD40 Expression in Proximal Renal Tubular Epithelial Cells and Enhances CD8+ Cytotoxic T-Cell Responses

  2007cites this paper
• Gene Transfer of Noncleavable Cell Surface Mutants of Human CD154 Induces the Immune Response and Diminishes Systemic Inflammatory Reactions

  2007cites this paper
• Genetics of clinical expression in SLE

  2007cites this paper
• Inflammation and the pathogenesis of atherosclerosis in systemic lupus erythematosus

  2006cites this paper
• Renal tubular epithelial expression of the coinhibitory molecule B7-DC (programmed death-1 ligand).

  2006cites this paper
• Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.

  2006cites this paper
• Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survival.

  2006cites this paper
• Effect of 15d-PGJ2 on the Expression of CD40 and RANTES Induced by IFN-γ and TNF-α on Renal Tubular Epithelial Cells (HK-2)

  2006cites this paper
• Implication of Peritubular Capillary Loss and Altered Expression of Vascular Endothelial Growth Factor in IgA Nephropathy

  2006cites this paper
• Effect of 15d-PGJ2 on the expression of CD40 and RANTES induced by IFN-gamma and TNF-alpha on renal tubular epithelial cells (HK-2).

  2006cites this paper
• CD40 ligand increases complement C3 secretion by proximal tubular epithelial cells.

  2005cites this paper
• Anti-CD40 monoclonal antibody

  2005cites this paper
• Haplotype structure of TNFRSF5-TNFSF5 (CD40–CD40L) and association analysis in systemic lupus erythematosus

  2005cites this paper
• [Platelet-associated CD154: a new interface in haemostasis and in the inflammatory reaction].

  2005cites this paper
• Tubular CD146 Expression in Nephropathies Is Related to Chronic Renal Failure

  2005cites this paper
• Treatment of glomerulonephritis: will we ever have options other than steroids and cytotoxics?

  2005cites this paper
• New therapies in systemic lupus erythematosus Mycophenolate mofetil

  2005cites this paper
• New therapies for systemic lupus erythematosus

  2005cites this paper
• Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40.

  2005cites this paper
• Tratamiento de la glomerulonefritis: ¿Tendremos alguna vez otras opciones ademas de los esteroides y citotoxicos?

  2005cites this paper
• Immunothérapies du lupus systémique : innovations et perspectives

  2005cites this paper
• Une nouvelle interface dans l'hémostase et la réaction inflammatoire

  2005cites this paper
• Reduced CD40L Expression on ex vivo Activated CD4+ T-Lymphocytes from Patients with Excellent Renal Allograft Function Measured with a Rapid Whole Blood Flow Cytometry Procedure

  2004cites this paper
• In situ Expression of CD40 and CD40 Ligand in Psoriasis

  2004cites this paper
• Immunotherapy Targeting the CD40/CD154 Costimulatory Pathway for Treatment of Autoimmune Disease

  2004cites this paper
• Recent advances in vascular inflammation: C-reactive protein and other inflammatory biomarkers

  2004cites this paper
• Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients

  2004cites this paper
• The dinucleotide repeat polymorphism in the 3′UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus

  2004cites this paper
• The role of CD40 ligand in systemic lupus erythematosus

  2004cites this paper
• Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli.

  2004cites this paper
• P-glycoprotein--a novel therapeutic target for immunomodulation in clinical transplantation and autoimmunity?

  2003cites this paper
• Cytokine balance in kidney tissue from lupus nephritis patients.

  2003cites this paper
• T cell costimulatory pathways: blockade for autoimmunity

  2003cites this paper
• A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis.

  2003cites this paper
• CD154 expression and mRNA stability of activated CD4-positive T cells in patients with systemic lupus erythematosus

  2003cites this paper